High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso
Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. During 2 months (June-July 2014),...
Saved in:
Published in | BMC infectious diseases Vol. 16; no. 1; p. 326 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
11.07.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.
During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.
ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.
This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination. |
---|---|
AbstractList | Background Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. Methods During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Muller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method. Results ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected. Conclusions This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination. Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.BACKGROUNDNothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.METHODSDuring 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.RESULTSESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination.CONCLUSIONSThis report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination. Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso. During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method. ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected. This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination. BACKGROUND:Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The objective of this study was to determine ESBL-PE prevalence and to characterize ESBL genes in Burkina Faso.METHODS:During 2 months (June-July 2014), 1602 clinical samples were sent for bacteriologic investigations to the microbiology laboratories of the tree main hospitals of Burkina Faso. Isolates were identified by mass spectrometry using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) BioTyper. Antibiotic susceptibility was tested using the disk diffusion method on Müller-Hinton agar. The different ESBL genes in potential ESBL-producing isolates were detected by PCR and double stranded DNA sequencing. Escherichia coli phylogenetic groups were determined using a PCR-based method.RESULTS:ESBL-PE frequency was 58 % (179 strains among the 308 Enterobacteriaceae isolates identified in the collected samples; 45 % in outpatients and 70 % in hospitalized patients). The CTX-M-1 group was dominant (94 %, CTX-M-15 enzyme), followed by the CTX-M-9 group (4 %). ESBL producers were more often found in E. coli (67.5 %) and Klebsiella pneumoniae (26 %) isolates. E. coli isolates (n = 202; 60 % of all Enterobacteriaceae samples) were distributed in eight phylogenetic groups (A = 49, B1 = 15, B2 = 43, C = 22, Clade I = 7, D = 37, F = 13 and 16 unknown); 22 strains belonged to the sequence type ST131. No association between a specific strain and ESBL production was detected.CONCLUSIONS:This report shows the alarming spread of ESBL genes in Burkina Faso. Public health efforts should focus on education (population and healthcare professionals), surveillance and promotion of correct and restricted antibiotic use to limit their dissemination. |
ArticleNumber | 326 |
Author | Poda, Armel Bouzinbi, Nicolas Ouedraogo, Abdoul-Salam Kaboré, Firmin Sanou, Soufiane Godreuil, Sylvain Kissou, Aimée Aberkane, Salim Decré, Dominique Nacro, Boubacar Sanou, Mahamadou Carrière, Christian Solaré, Hermann Sangaré, Lassana Ouégraogo, Rasmata Sano, Idrissa Jean-Pierre, Hélène |
Author_xml | – sequence: 1 givenname: Abdoul-Salam surname: Ouedraogo fullname: Ouedraogo, Abdoul-Salam – sequence: 2 givenname: Mahamadou surname: Sanou fullname: Sanou, Mahamadou – sequence: 3 givenname: Aimée surname: Kissou fullname: Kissou, Aimée – sequence: 4 givenname: Soufiane surname: Sanou fullname: Sanou, Soufiane – sequence: 5 givenname: Hermann surname: Solaré fullname: Solaré, Hermann – sequence: 6 givenname: Firmin surname: Kaboré fullname: Kaboré, Firmin – sequence: 7 givenname: Armel surname: Poda fullname: Poda, Armel – sequence: 8 givenname: Salim surname: Aberkane fullname: Aberkane, Salim – sequence: 9 givenname: Nicolas surname: Bouzinbi fullname: Bouzinbi, Nicolas – sequence: 10 givenname: Idrissa surname: Sano fullname: Sano, Idrissa – sequence: 11 givenname: Boubacar surname: Nacro fullname: Nacro, Boubacar – sequence: 12 givenname: Lassana surname: Sangaré fullname: Sangaré, Lassana – sequence: 13 givenname: Christian surname: Carrière fullname: Carrière, Christian – sequence: 14 givenname: Dominique surname: Decré fullname: Decré, Dominique – sequence: 15 givenname: Rasmata surname: Ouégraogo fullname: Ouégraogo, Rasmata – sequence: 16 givenname: Hélène surname: Jean-Pierre fullname: Jean-Pierre, Hélène – sequence: 17 givenname: Sylvain surname: Godreuil fullname: Godreuil, Sylvain |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27400864$$D View this record in MEDLINE/PubMed https://hal.science/hal-01862672$$DView record in HAL |
BookMark | eNp1ks1u1DAUhSNURH_gAdggS2xgEfBPYicbpFJRBmkkNrC2buybGZfEHuxkBE_Th-mL4WhaVEZiZcv3O-dc2_e8OPHBY1G8ZPQdY418nxhvVFtSJksm67oUT4ozVilWciGqk0f70-I8pRtKmWp4-6w45aqitJHVWbFfuc2W7CLuYUBvkISe4K8JvUVbph2aKc4jubstBzATjJAww8HOxvkNQT9hDF2uYHRgEJDAGHLBDM47AwNxKQwwYSLOk49z_OE8kGtI4XnxtIch4Yv79aL4fv3p29WqXH_9_OXqcl0aoaQoawa2Rd4p25m-RcpN3YmGS8pAmcpa3tW27m3XgmEVraw0nQRbyV7xvqFWiYviw8F3N3cjWpM7jjDoXXQjxN86gNP_Vrzb6k3Y66oVbd0sBm8PBtsj2epyrZczmj-CS8X3LLNv7sNi-DljmvToksFhAI9hTpo1VKhWtdWCvj5Cb8IcfX6KhVJNjmZL-KvH3f_Nf_i-DKgDYGJIKWKvjZtgcmG5jBs0o3oZFH0YlNyr1MugaJGV7Ej5YP5_zR9Q9cK7 |
CitedBy_id | crossref_primary_10_2147_IDR_S349566 crossref_primary_10_1016_j_medmal_2018_07_007 crossref_primary_10_3390_app13010442 crossref_primary_10_3390_genes15080985 crossref_primary_10_1155_2022_5727638 crossref_primary_10_1186_s13756_021_00941_8 crossref_primary_10_5897_AJPP2021_5290 crossref_primary_10_2147_IDR_S363988 crossref_primary_10_2147_IDR_S358116 crossref_primary_10_5897_AJMR2021_9489 crossref_primary_10_1111_tmi_13644 crossref_primary_10_3389_fmicb_2020_567235 crossref_primary_10_3390_antibiotics13010093 crossref_primary_10_3389_fmicb_2017_01904 crossref_primary_10_3390_antibiotics10070835 crossref_primary_10_1089_mdr_2018_0314 crossref_primary_10_30699_ijmm_16_6_490 crossref_primary_10_1186_s42522_023_00081_6 crossref_primary_10_4236_jbm_2025_131030 crossref_primary_10_3390_microbiolres15040153 crossref_primary_10_1186_s12887_019_1709_y crossref_primary_10_1089_sur_2023_375 crossref_primary_10_1016_j_ijantimicag_2020_106203 crossref_primary_10_1007_s13353_022_00718_8 crossref_primary_10_3390_tropicalmed6040179 crossref_primary_10_3389_fcimb_2023_1322874 crossref_primary_10_1371_journal_pone_0172652 crossref_primary_10_14202_IJOH_2024_12_19 crossref_primary_10_61186_JoMMID_11_2_110 crossref_primary_10_5897_AJMR2017_8778 crossref_primary_10_5897_AJMR2017_8535 crossref_primary_10_1186_s12879_023_08742_7 crossref_primary_10_1371_journal_pone_0222911 crossref_primary_10_1016_j_jgar_2020_04_010 crossref_primary_10_1186_s13756_023_01220_4 crossref_primary_10_1371_journal_pone_0268991 crossref_primary_10_3390_medsci7110104 crossref_primary_10_4103_jdrntruhs_jdrntruhs_105_21 crossref_primary_10_2147_IDR_S485200 crossref_primary_10_3390_tropicalmed4030117 crossref_primary_10_1186_s40001_024_02267_8 crossref_primary_10_2147_IDR_S269425 crossref_primary_10_1007_s10096_023_04629_2 crossref_primary_10_5812_iji_83194 crossref_primary_10_1089_mdr_2020_0497 crossref_primary_10_3389_fcimb_2022_955774 crossref_primary_10_2174_2211352519666210422131526 crossref_primary_10_1186_s13756_019_0488_4 crossref_primary_10_1186_s13756_020_00856_w crossref_primary_10_1155_2020_6679029 crossref_primary_10_3390_antibiotics13111059 crossref_primary_10_1007_s00003_024_01493_w crossref_primary_10_1016_j_heliyon_2020_e03206 crossref_primary_10_1080_14789450_2017_1260451 crossref_primary_10_1111_tmi_13868 crossref_primary_10_3390_antibiotics12010148 crossref_primary_10_33393_dti_2023_2613 crossref_primary_10_1016_j_sciaf_2022_e01106 crossref_primary_10_4236_ojmm_2023_131004 crossref_primary_10_37376_ljst_v14i1_7170 crossref_primary_10_1186_s12879_019_3838_1 crossref_primary_10_14202_IJOH_2022_124_160 crossref_primary_10_5897_AJMR2017_8598 crossref_primary_10_7759_cureus_40183 crossref_primary_10_1099_acmi_0_000195 crossref_primary_10_1186_s12866_024_03485_0 crossref_primary_10_3390_antibiotics12061016 crossref_primary_10_1371_journal_pone_0274156 crossref_primary_10_1155_2024_7463899 crossref_primary_10_1186_s12887_020_02342_z crossref_primary_10_2147_IDR_S442646 crossref_primary_10_1186_s13104_018_3581_5 |
Cites_doi | 10.1111/j.1469-0691.2008.02074.x 10.1128/AAC.00675-09 10.1111/1758-2229.12019 10.1086/500936 10.1093/jac/dkp498 10.1007/s10096-014-2141-8 10.1128/JCM.43.7.3309-3313.2005 10.1016/j.diagmicrobio.2010.11.011 10.1111/j.1469-0691.2007.01867.x 10.1093/clinids/10.4.867 10.1186/1471-2180-12-155 10.1007/s10096-003-1084-2 10.1128/CMR.18.4.657-686.2005 10.1007/s10096-008-0656-6 10.3201/eid1402.070350 10.2147/IDR.S74934 10.1186/1471-2334-10-204 10.1016/j.medmal.2015.08.003 10.1080/21548331.2016.1133214 10.2807/ese.13.47.19044-en 10.1089/mdr.2009.0108 10.1016/j.mib.2006.08.011 10.1093/jac/dkm144 10.17305/bjbms.2011.2588 10.1186/1476-0711-12-16 10.1111/j.1469-0691.2007.01866.x 10.1046/j.1469-0691.2000.00002.x 10.1089/mdr.1999.5.189 10.1093/jac/dkl199 10.3402/iee.v4.20342 10.1093/jac/dkp194 10.1038/ja.2012.91 10.1093/jac/dkm381 10.4269/ajtmh.12-0642 10.1016/j.urology.2013.02.040 10.1016/j.ajic.2005.03.009 10.1186/2047-2994-1-23 10.1111/j.1469-0691.2007.01850.x 10.1155/2015/846219 10.1016/j.ijantimicag.2006.01.007 10.1007/s10096-012-1717-4 |
ContentType | Journal Article |
Copyright | Copyright BioMed Central 2016 Attribution The Author(s). 2016 |
Copyright_xml | – notice: Copyright BioMed Central 2016 – notice: Attribution – notice: The Author(s). 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES 5PM |
DOI | 10.1186/s12879-016-1655-3 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
ExternalDocumentID | PMC4939587 oai_HAL_hal_01862672v1 4133661141 27400864 10_1186_s12879_016_1655_3 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM 7QL 7T2 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 1XC VOOES 5PM |
ID | FETCH-LOGICAL-c3763-51ad9e2b7dbcf9e02c5b382601a7c4dd2b5d5fdb9ac1404d6cb6ad46f72f80d73 |
IEDL.DBID | M48 |
ISSN | 1471-2334 |
IngestDate | Thu Aug 21 17:45:49 EDT 2025 Thu Aug 14 06:50:33 EDT 2025 Fri Jul 11 07:22:30 EDT 2025 Fri Jul 25 07:02:44 EDT 2025 Thu Jan 02 23:11:54 EST 2025 Thu Apr 24 23:03:39 EDT 2025 Tue Jul 01 01:57:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | ESBL Burkina Faso Clinical samples Inpatient and outpatient Enterobacteriaceae |
Language | English |
License | Attribution: http://creativecommons.org/licenses/by Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3763-51ad9e2b7dbcf9e02c5b382601a7c4dd2b5d5fdb9ac1404d6cb6ad46f72f80d73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 PMCID: PMC4939587 |
ORCID | 0000-0002-8539-3768 0000-0003-3436-0082 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-016-1655-3 |
PMID | 27400864 |
PQID | 1807858717 |
PQPubID | 42582 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4939587 hal_primary_oai_HAL_hal_01862672v1 proquest_miscellaneous_1803797941 proquest_journals_1807858717 pubmed_primary_27400864 crossref_citationtrail_10_1186_s12879_016_1655_3 crossref_primary_10_1186_s12879_016_1655_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-07-11 |
PublicationDateYYYYMMDD | 2016-07-11 |
PublicationDate_xml | – month: 07 year: 2016 text: 2016-07-11 day: 11 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2016 |
Publisher | BioMed Central |
Publisher_xml | – name: BioMed Central |
References | 1655_CR17 1655_CR39 1655_CR14 D Iranpour (1655_CR46) 2015; 2015 1655_CR15 1655_CR12 1655_CR13 DL Paterson (1655_CR6) 2005; 18 1655_CR32 1655_CR11 1655_CR33 H Zhang (1655_CR36) 2015; 6 1655_CR30 J Rodriguez-Bano (1655_CR25) 2008; 14 GM Rossolini (1655_CR5) 2008; 14 J Gangoue-Pieboji (1655_CR29) 2006; 6 R Colodner (1655_CR3) 2004; 23 R Ben-Ami (1655_CR28) 2006; 42 N Obeng-Nkrumah (1655_CR7) 2013; 89 C Dallenne (1655_CR9) 2010; 65 RA Afunwa (1655_CR24) 2011; 11 G Peirano (1655_CR34) 2011; 69 1655_CR18 S Dahmen (1655_CR40) 2010; 16 1655_CR19 1655_CR27 J Silva (1655_CR35) 1999; 5 ZA Kanafani (1655_CR16) 2005; 33 O Clermont (1655_CR10) 2013; 5 1655_CR23 1655_CR45 V Jarlier (1655_CR8) 1988; 10 1655_CR43 MH Mohamed Al-Agamy (1655_CR38) 2006; 27 1655_CR44 JJ Rahal (1655_CR1) 2000; 6 R Raz (1655_CR26) 2000; 2 R Canton (1655_CR4) 2006; 9 1655_CR42 T Nakayama (1655_CR22) 2015; 8 EA Newire (1655_CR2) 2013; 12 MM Oh (1655_CR21) 2013; 81 CM Lonchel (1655_CR41) 2013; 32 J Kiiru (1655_CR37) 2012; 12 T Hara (1655_CR31) 2015; 68 M Kumar (1655_CR20) 2015; 9 26433872 - Med Mal Infect. 2015 Sep;45(9):374-82 3263690 - Rev Infect Dis. 1988 Jul-Aug;10(4):867-78 19721071 - Antimicrob Agents Chemother. 2009 Nov;53(11):4957-8 24043693 - Am J Trop Med Hyg. 2013 Nov;89(5):960-4 16717055 - J Antimicrob Chemother. 2006 Jul;58(1):205-10 22958481 - Antimicrob Resist Infect Control. 2012 Jun 06;1(1):23 18154526 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41 26673518 - Hosp Pract (1995). 2016;44(1):33-40 10566868 - Microb Drug Resist. 1999 Fall;5(3):189-93 25870591 - Front Microbiol. 2015 Mar 27;6:239 16511754 - Clin Infect Dis. 2006 Apr 1;42(7):925-34 16223952 - Clin Microbiol Rev. 2005 Oct;18(4):657-86 25670909 - Infect Drug Resist. 2015 Jan 23;8:1-5 18154538 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53 20071363 - J Antimicrob Chemother. 2010 Mar;65(3):490-5 14986159 - Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7 20624313 - BMC Infect Dis. 2010 Jul 12;10:204 16942899 - Curr Opin Microbiol. 2006 Oct;9(5):466-75 23601450 - Urology. 2013 Jun;81(6):1209-12 18154533 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10 16061138 - Am J Infect Control. 2005 Aug;33(6):326-32 19021958 - Euro Surveill. 2008 Nov 20;13(47):null 18828851 - Clin Microbiol Infect. 2008 Oct;14(10):895-907 24807441 - Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1719-23 18258110 - Emerg Infect Dis. 2008 Feb;14(2):195-200 19474064 - J Antimicrob Chemother. 2009 Aug;64(2):274-7 16713187 - Int J Antimicrob Agents. 2006 Jun;27(6):545-8 23757131 - Environ Microbiol Rep. 2013 Feb;5(1):58-65 11523521 - Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6 24765249 - Infect Ecol Epidemiol. 2014 Mar 13;4:null 16000453 - J Clin Microbiol. 2005 Jul;43(7):3309-13 22838634 - BMC Microbiol. 2012 Jul 28;12:155 26182812 - Jpn J Antibiot. 2015 Apr;68(2):75-84 20438347 - Microb Drug Resist. 2010 Jun;16(2):163-70 17604512 - Afr Health Sci. 2006 Dec;6(4):232-5 17496058 - J Antimicrob Chemother. 2007 Jul;60(1):140-4 25692147 - Biomed Res Int. 2015;2015:846219 10897231 - Isr Med Assoc J. 2000 Jun;2(6):426-9 23866018 - Ann Clin Microbiol Antimicrob. 2013 Jul 18;12:16 23093031 - J Antibiot (Tokyo). 2013 Jan;66(1):11-6 21396544 - Diagn Microbiol Infect Dis. 2011 Apr;69(4):449-53 21619555 - Bosn J Basic Med Sci. 2011 May;11(2):91-6 22886058 - Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):79-87 19002728 - Eur J Clin Microbiol Infect Dis. 2009 May;28(5):491-8 17913717 - J Antimicrob Chemother. 2007 Dec;60(6):1370-4 26675893 - J Clin Diagn Res. 2015 Nov;9(11):DC08-13 |
References_xml | – ident: 1655_CR17 doi: 10.1111/j.1469-0691.2008.02074.x – volume: 6 start-page: 232 issue: 4 year: 2006 ident: 1655_CR29 publication-title: Cameroon Afr Health Sci – ident: 1655_CR39 doi: 10.1128/AAC.00675-09 – volume: 5 start-page: 58 issue: 1 year: 2013 ident: 1655_CR10 publication-title: Environ Microbiol Rep doi: 10.1111/1758-2229.12019 – volume: 42 start-page: 925 issue: 7 year: 2006 ident: 1655_CR28 publication-title: Clin Infect Dis doi: 10.1086/500936 – volume: 65 start-page: 490 issue: 3 year: 2010 ident: 1655_CR9 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkp498 – ident: 1655_CR45 doi: 10.1007/s10096-014-2141-8 – ident: 1655_CR43 doi: 10.1128/JCM.43.7.3309-3313.2005 – volume: 69 start-page: 449 issue: 4 year: 2011 ident: 1655_CR34 publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2010.11.011 – volume: 14 start-page: 33 issue: Suppl 1 year: 2008 ident: 1655_CR5 publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2007.01867.x – volume: 10 start-page: 867 issue: 4 year: 1988 ident: 1655_CR8 publication-title: Rev Infect Dis doi: 10.1093/clinids/10.4.867 – volume: 12 start-page: 155 year: 2012 ident: 1655_CR37 publication-title: BMC Microbiol doi: 10.1186/1471-2180-12-155 – volume: 23 start-page: 163 issue: 3 year: 2004 ident: 1655_CR3 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-003-1084-2 – volume: 18 start-page: 657 issue: 4 year: 2005 ident: 1655_CR6 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.18.4.657-686.2005 – ident: 1655_CR30 doi: 10.1007/s10096-008-0656-6 – ident: 1655_CR42 doi: 10.3201/eid1402.070350 – volume: 8 start-page: 1 year: 2015 ident: 1655_CR22 publication-title: Infect Drug Resist doi: 10.2147/IDR.S74934 – ident: 1655_CR27 doi: 10.1186/1471-2334-10-204 – ident: 1655_CR18 doi: 10.1016/j.medmal.2015.08.003 – ident: 1655_CR19 doi: 10.1080/21548331.2016.1133214 – ident: 1655_CR13 doi: 10.2807/ese.13.47.19044-en – volume: 16 start-page: 163 issue: 2 year: 2010 ident: 1655_CR40 publication-title: Microb Drug Resist doi: 10.1089/mdr.2009.0108 – volume: 9 start-page: 466 issue: 5 year: 2006 ident: 1655_CR4 publication-title: Curr Opin Microbiol doi: 10.1016/j.mib.2006.08.011 – ident: 1655_CR32 doi: 10.1093/jac/dkm144 – volume: 11 start-page: 91 issue: 2 year: 2011 ident: 1655_CR24 publication-title: Bosn J Basic Med Sci doi: 10.17305/bjbms.2011.2588 – volume: 12 start-page: 16 year: 2013 ident: 1655_CR2 publication-title: Ann Clin Microbiol Antimicrob doi: 10.1186/1476-0711-12-16 – volume: 14 start-page: 104 issue: Suppl 1 year: 2008 ident: 1655_CR25 publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2007.01866.x – volume: 6 start-page: 2 issue: Suppl 2 year: 2000 ident: 1655_CR1 publication-title: Clin Microbiol Infect doi: 10.1046/j.1469-0691.2000.00002.x – volume: 5 start-page: 189 issue: 3 year: 1999 ident: 1655_CR35 publication-title: Microb Drug Resist doi: 10.1089/mdr.1999.5.189 – ident: 1655_CR44 doi: 10.1093/jac/dkl199 – volume: 9 start-page: DC08 issue: 11 year: 2015 ident: 1655_CR20 publication-title: J Clin Diagn Res – volume: 68 start-page: 75 issue: 2 year: 2015 ident: 1655_CR31 publication-title: Jpn J Antibiot – ident: 1655_CR14 doi: 10.3402/iee.v4.20342 – ident: 1655_CR11 doi: 10.1093/jac/dkp194 – ident: 1655_CR23 doi: 10.1038/ja.2012.91 – ident: 1655_CR33 doi: 10.1093/jac/dkm381 – volume: 6 start-page: 239 year: 2015 ident: 1655_CR36 publication-title: China Front Microbiol – volume: 89 start-page: 960 issue: 5 year: 2013 ident: 1655_CR7 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.12-0642 – volume: 81 start-page: 1209 issue: 6 year: 2013 ident: 1655_CR21 publication-title: Urology doi: 10.1016/j.urology.2013.02.040 – volume: 33 start-page: 326 issue: 6 year: 2005 ident: 1655_CR16 publication-title: Am J Infect Control doi: 10.1016/j.ajic.2005.03.009 – ident: 1655_CR15 doi: 10.1186/2047-2994-1-23 – volume: 2 start-page: 426 issue: 6 year: 2000 ident: 1655_CR26 publication-title: Isr Med Assoc J – ident: 1655_CR12 doi: 10.1111/j.1469-0691.2007.01850.x – volume: 2015 start-page: 846219 year: 2015 ident: 1655_CR46 publication-title: Biomed Res Int doi: 10.1155/2015/846219 – volume: 27 start-page: 545 issue: 6 year: 2006 ident: 1655_CR38 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2006.01.007 – volume: 32 start-page: 79 issue: 1 year: 2013 ident: 1655_CR41 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/s10096-012-1717-4 – reference: 16061138 - Am J Infect Control. 2005 Aug;33(6):326-32 – reference: 22886058 - Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):79-87 – reference: 11523521 - Clin Microbiol Infect. 2000 Aug;6 Suppl 2:2-6 – reference: 22838634 - BMC Microbiol. 2012 Jul 28;12:155 – reference: 23866018 - Ann Clin Microbiol Antimicrob. 2013 Jul 18;12:16 – reference: 20071363 - J Antimicrob Chemother. 2010 Mar;65(3):490-5 – reference: 17604512 - Afr Health Sci. 2006 Dec;6(4):232-5 – reference: 26673518 - Hosp Pract (1995). 2016;44(1):33-40 – reference: 26433872 - Med Mal Infect. 2015 Sep;45(9):374-82 – reference: 16717055 - J Antimicrob Chemother. 2006 Jul;58(1):205-10 – reference: 24043693 - Am J Trop Med Hyg. 2013 Nov;89(5):960-4 – reference: 25692147 - Biomed Res Int. 2015;2015:846219 – reference: 21619555 - Bosn J Basic Med Sci. 2011 May;11(2):91-6 – reference: 19721071 - Antimicrob Agents Chemother. 2009 Nov;53(11):4957-8 – reference: 18828851 - Clin Microbiol Infect. 2008 Oct;14(10):895-907 – reference: 23093031 - J Antibiot (Tokyo). 2013 Jan;66(1):11-6 – reference: 24807441 - Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1719-23 – reference: 16713187 - Int J Antimicrob Agents. 2006 Jun;27(6):545-8 – reference: 24765249 - Infect Ecol Epidemiol. 2014 Mar 13;4:null – reference: 18154526 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41 – reference: 19002728 - Eur J Clin Microbiol Infect Dis. 2009 May;28(5):491-8 – reference: 26675893 - J Clin Diagn Res. 2015 Nov;9(11):DC08-13 – reference: 18154538 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53 – reference: 23601450 - Urology. 2013 Jun;81(6):1209-12 – reference: 19021958 - Euro Surveill. 2008 Nov 20;13(47):null – reference: 18258110 - Emerg Infect Dis. 2008 Feb;14(2):195-200 – reference: 21396544 - Diagn Microbiol Infect Dis. 2011 Apr;69(4):449-53 – reference: 10566868 - Microb Drug Resist. 1999 Fall;5(3):189-93 – reference: 19474064 - J Antimicrob Chemother. 2009 Aug;64(2):274-7 – reference: 16511754 - Clin Infect Dis. 2006 Apr 1;42(7):925-34 – reference: 14986159 - Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7 – reference: 16000453 - J Clin Microbiol. 2005 Jul;43(7):3309-13 – reference: 17496058 - J Antimicrob Chemother. 2007 Jul;60(1):140-4 – reference: 16942899 - Curr Opin Microbiol. 2006 Oct;9(5):466-75 – reference: 25870591 - Front Microbiol. 2015 Mar 27;6:239 – reference: 18154533 - Clin Microbiol Infect. 2008 Jan;14 Suppl 1:104-10 – reference: 26182812 - Jpn J Antibiot. 2015 Apr;68(2):75-84 – reference: 17913717 - J Antimicrob Chemother. 2007 Dec;60(6):1370-4 – reference: 23757131 - Environ Microbiol Rep. 2013 Feb;5(1):58-65 – reference: 16223952 - Clin Microbiol Rev. 2005 Oct;18(4):657-86 – reference: 20624313 - BMC Infect Dis. 2010 Jul 12;10:204 – reference: 3263690 - Rev Infect Dis. 1988 Jul-Aug;10(4):867-78 – reference: 10897231 - Isr Med Assoc J. 2000 Jun;2(6):426-9 – reference: 22958481 - Antimicrob Resist Infect Control. 2012 Jun 06;1(1):23 – reference: 20438347 - Microb Drug Resist. 2010 Jun;16(2):163-70 – reference: 25670909 - Infect Drug Resist. 2015 Jan 23;8:1-5 |
SSID | ssj0017829 |
Score | 2.4082928 |
Snippet | Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina Faso. The... Background Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina... BACKGROUND:Nothing is known about the epidemiology and resistance mechanisms of extended-spectrum ß-lactamase-producing Enterobacteriaceae (ESBL-PE) in Burkina... |
SourceID | pubmedcentral hal proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 326 |
SubjectTerms | Adolescent Adult Aged Anti-Bacterial Agents - pharmacology beta-Lactamases - analysis beta-Lactamases - classification beta-Lactamases - genetics Burkina Faso - epidemiology Child Child, Preschool DNA, Bacterial - analysis DNA, Bacterial - isolation & purification DNA, Bacterial - metabolism Enterobacteriaceae - drug effects Enterobacteriaceae - enzymology Enterobacteriaceae - isolation & purification Enterobacteriaceae Infections - epidemiology Enterobacteriaceae Infections - microbiology Enterobacteriaceae Infections - pathology Escherichia coli - drug effects Escherichia coli - enzymology Escherichia coli - isolation & purification Female Human health and pathology Humans Infant Infant, Newborn Infectious diseases Klebsiella pneumoniae - drug effects Klebsiella pneumoniae - enzymology Klebsiella pneumoniae - isolation & purification Life Sciences Male Middle Aged Odds Ratio Phylogeny Prevalence Sequence Analysis, DNA Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokRAXRHl1oUUGcUKyGjt-5YRK1dUKUU5U2lvkR6Ku1CbLbrd_hx_DH2PG6wQWpF5jJ3Ey43n7G0I-VFE7baJipZOKSRMr5r2SDCwTLgpvhEiHwi6-6dml_DJX8xxwW-eyykEmJkEd-4Ax8hOOwOgKzHvzafmDYdcozK7mFhp75CFCl2FJl5mPDhcH7VflTCa3-mQNsthgdZBmXCtY3o4u2rvCSsj_zcx_qyX_Uj_Tp-RJthvp6ZbQB-RB0z0jjy5yZvw5ucOCDbpcIXo3blbat3QIcLN0nHK1uaG_frJrF27dDeguukxgr6C6KOJyrmBjJ-BmFxrX0NSEiA7nJukCWBStUrro6OcNxtcdnbp1_4JcTs-_n81Y7qnAAooSpriLVSO8iT60VVOIoHxpEVfMmSBjFF5F1UZfuYDAO1EHr12UujWitUU05Uuy3_Vdc0ioCqBgCx9ty9GptN5KK0W0IrSuLbWckGL4u3XIgOPY9-K6To6H1fWWIDUWmSFB6nJCPo63LLdoG_dNfg8kG-chTvbs9GuN1wqOjpoRd3xCjgaK1nl3rus_vDQh78Zh2FeYLHFd02_SnNJUIK3gEa-2DDC-Cjx5dAXhC80Oa-ysZXekW1wl7G5ZlcCn5vX9y3pDHgtkUwTw5EdkH1ikOQbj59a_TRz-G-xzBbY priority: 102 providerName: ProQuest |
Title | High prevalence of extended-spectrum ß-lactamase producing enterobacteriaceae among clinical isolates in Burkina Faso |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27400864 https://www.proquest.com/docview/1807858717 https://www.proquest.com/docview/1803797941 https://hal.science/hal-01862672 https://pubmed.ncbi.nlm.nih.gov/PMC4939587 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELaaVkJcEO8GSmQQJyTDrtevPSDUVI0iRCpUESnisvJjV42UbkLSVPBr-DH8MWac3UCg4sBlD2t7vfLMeGY8428IeZkHZZUOkmVWSCZ0yJlzUjCwTFKeOM15vBQ2OlPDsXg_kZM90pa3ahZwdaNrh_WkxsvZ669fvr0DgX8bBd6oNyvYYzVm_SiWKgnTdsgBKCaNcjoSv4IKoAzzJrB54zAEBtYCjXyxo6U6F5gj-bcB-mce5W-KaXCX3GksSnq8YYF7ZK-s75NboyZm_oBcYyoHXSwR1xvFmM4r2h59s3jRcrm-pD--s5n1V_YStBpdRBhYUGoUETuXIPIR0tn60pY0liei7Y1KOgXmRXuVTmvaX-PJu6UDu5o_JOPB6aeTIWuqLTCPmwyTqQ15yZ0Ozld5mXAvXWYQccxqL0LgTgZZBZdbj5A8QXmnbBCq0rwySdDZI7Jfz-vykFDpQfUmLpgqRXfTOCOM4MFwX9kqU6JLknZ1C99AkWNFjFkRXRKjig1tCkw_Q9oUWZe82g5ZbHA4_tX5BZBs2w8RtIfHHwp8l6Towml-nXbJUUvRomW7IkX4fQlOpO6S59tmkDgMo9i6nK9jn0znsI_BJx5vGGA7Vcs_XaJ3WGPnX3Zb6ulFRPUWeZbDzE_-e-RTcpsjMyPqZ3pE9oF7ymdgMV25HunoiYanOUl75KB_evbxvBdPH3pRQuB53v_8E4AnG1E |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLbaIgGXip0pBQyCC5LVxPGSHBAqy2hKZ3pqpbkFL4k6UpsMM50ifg3_gD_BH-M9Z4EBqbdeY8dO_Hb7-XuEvMq8Mkp7yRIjJBPaZ8xaKRh4JjGPrOY8XAqbHKnRifg8ldMN8rO7C4NplZ1ODIra1w73yPdiBEaX4N7rd_OvDKtG4elqV0KjYYvD4vs3CNmWbw8-An1fcz78dPxhxNqqAsyhMDEZG58V3GpvXZkVEXfSJikiaxnthPfcSi9LbzPjEHrGK2eV8UKVmpdp5HUC426SG2B4I5QoPe0DvBisbdaenMap2luC7teYjaRYrCQsx5rt2zzFzMv_3dp_szP_MnfDO2S79VPpfsNYd8lGUd0jNyftSfx9cokJInS-QLRwVA60Lmm3oc7C9c3F6pz--sHOjLsw52Ar6TyAy4KppIgDugBFEoCijStMQUPRI9rd06QzEAn0gumsou9XuJ9v6NAs6wfk5FpW-yHZquqqeEyodGDQI-vTMsYgNrWpSAX3KXelKRMlBiTqVjd3LcA51tk4y0Ogk6q8IUiOSW1IkDwZkDf9K_MG3eOqzi-BZH0_xOUe7Y9zfBbFGBhqfhkPyG5H0bzVBsv8D-8OyIu-GeQYD2dMVdSr0CfRGWhHGOJRwwD9VFwLDD3hD_Uaa6x9y3pLNTsNWOEiSzKYeefqz3pObo2OJ-N8fHB0-ITc5siyCB4a75ItYJfiKTheF_ZZ4HZKvly3eP0Gvy1EAQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+prevalence+of+extended-spectrum+%C3%9F-lactamase+producing+enterobacteriaceae+among+clinical+isolates+in+Burkina+Faso&rft.jtitle=BMC+infectious+diseases&rft.au=Ouedraogo%2C+Abdoul-Salam&rft.au=Sanou%2C+Mahamadou&rft.au=Kissou%2C+Aim%C3%A9e&rft.au=Sanou%2C+Soufiane&rft.date=2016-07-11&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=16&rft_id=info:doi/10.1186%2Fs12879-016-1655-3&rft_id=info%3Apmid%2F27400864&rft.externalDocID=PMC4939587 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |